Cargando…
Corrigendum to “The potential of miRNA-based therapeutics in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection: A review” [J. Pharma. Anal. 11 (2021) 265–271]
Autores principales: | Dwi Rizkita, Leonny, Astuti, Indwiani |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Xi'an Jiaotong University
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9770015/ https://www.ncbi.nlm.nih.gov/pubmed/36573113 http://dx.doi.org/10.1016/j.jpha.2022.11.001 |
Ejemplares similares
-
The potential of miRNA-based therapeutics in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection: A review
por: Rizkita, Leonny Dwi, et al.
Publicado: (2021) -
Corrigendum to “Evaluation of a health-promoting school program to enhance correct medication use in Taiwan” [J Food Drug Anal 22 (2014) 271–278]
por: Chi, Hsueh-Yun, et al.
Publicado: (2016) -
Corrigendum to “Self-isolation” [J. Math. Econom. 93 (2021) 102483]
por: Baril-Tremblay, Dominique, et al.
Publicado: (2022) -
Corrigendum to “Investigation of borneols sold in Taiwan by chiral gas chromatography” [J Food Drug Anal 26 (2018) 348–352]
por: Ho, Tsung-Jung, et al.
Publicado: (2019) -
Corrigendum to “Assessment of the pharmacokinetics, removal rate of hemodialysis, and safety of lactulose in hemodialysis patients” [J Food Drug Anal 24 (2016) 876–880]
por: Lin, Cheng-Jui, et al.
Publicado: (2017)